Stone House Investment Management’s GSK GSK Stock Holding History

Stone House Investment Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-217	Closed	-$8.41K	–	540
2025 Q1	$8.41K	Buy	+217	New	+$7.94K	﹤0.01%	269
2024 Q4	–	Sell	-438	Closed	-$17.9K	–	179
2024 Q3	$17.9K	Sell	438 -180	-29%	-$7.36K	﹤0.01%	184
2024 Q2	$23.8K	Sell	618 -80	-11%	-$3.37K	0.01%	174
2024 Q1	$29.9K	Buy	+698	New	+$28.8K	0.01%	162

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Stone House Investment Management's GSK Position: Q2 2025 in Review

Stone House Investment Management sold out of GSK (GSK) in Q2 2025, closing a stake of 217 shares — an estimated $8.41K sold.

Stone House Investment Management first reported a position in GSK in Q1 2024 and held it in 4 quarters. The position peaked at $29.9K in Q1 2024. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

Stone House Investment Management reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
Stone House Investment Management sold 217 GSK shares in Q2 2025, an estimated $8.41K.
Stone House Investment Management first reported a position in GSK in Q1 2024 and held it in 4 quarters.
Stone House Investment Management's GSK position peaked at $29.9K in Q1 2024.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on Stone House Investment Management's 13F filing for Q2 2025, filed 6 Aug 2025.